Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGAA in Classical Infantile Pompe Disease
NCT00025896Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2001
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alglucosidase alfa in Infantile-onset Pompe disease (IOPD), sponsored by Sanofi. Started May 2001; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Infantile-onset Pompe disease (IOPD)
Beyond the preview
Go deeper on NCT00025896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025896.